Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates

Paola Hernández, Rosario Rojas, Robert H. Gilman, Michel Sauvain, Lidia M. Lima, Eliezer J. Barreiro, Mercedes González, Hugo Cerecetto

Open source

DOI
10.1016/j.ejmech.2012.10.047
Published
2013-01
Container
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2012.10.047,
  title = {Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates},
  author = {Paola Hernández and Rosario Rojas and Robert H. Gilman and Michel Sauvain and Lidia M. Lima and Eliezer J. Barreiro and Mercedes González and Hugo Cerecetto},
  year = {2013},
  journal = {European Journal of Medicinal Chemistry},
  doi = {10.1016/j.ejmech.2012.10.047},
  url = {https://doi.org/10.1016/j.ejmech.2012.10.047}
}

RIS

TY  - JOUR
TI  - Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates
AU  - Paola Hernández
AU  - Rosario Rojas
AU  - Robert H. Gilman
AU  - Michel Sauvain
AU  - Lidia M. Lima
AU  - Eliezer J. Barreiro
AU  - Mercedes González
AU  - Hugo Cerecetto
PY  - 2013
JO  - European Journal of Medicinal Chemistry
DO  - 10.1016/j.ejmech.2012.10.047
UR  - https://doi.org/10.1016/j.ejmech.2012.10.047
ER  - 

APA

Hernández, P., Rojas, R., Gilman, R. H., Sauvain, M., Lima, L. M., Barreiro, E. J., González, M., & Cerecetto, H. (2013). Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2012.10.047

Source records